Evidence map›Paper›PMID 31722988›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2019

Efficient CRISPR/Cas9 Disruption of Autoimmune-Associated Genes Reveals Key Signaling Programs in Primary Human T Cells.

Warren Anderson, Jerill Thorpe, S Alice Long, David J Rawlings

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. eLife · 2023
    Article
  4. Article
  5. CRISPR/Cas9-Mediated Insertion of HIV Long Terminal Repeat withinJournal of immunology (Baltimore, Md. : 1950) · 2022
    Article
  6. Article
  7. Review
  8. Review
  9. CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy.Journal of experimental & clinical cancer research : CR · 2021
    Review
  10. Review
  11. Overexpression of theJournal of immunology (Baltimore, Md. : 1950) · 2021
    Article
  12. Review
  13. T cells selectively filter oscillatory signals on the minutes timescale.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  14. Review
  15. Article
  16. Influence ofFrontiers in immunology · 2021
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Warren AndersonCenter for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA 98101.ORCID 0000-0002-9315-5233
Jerill ThorpeBenaroya Research Institute at Virginia Mason, Seattle, WA 98101.
S Alice LongBenaroya Research Institute at Virginia Mason, Seattle, WA 98101.
David J RawlingsCenter for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA 98101; drawling@u.washington.edu.ORCID 0000-0002-0810-1776
University of Washington · USVirginia Mason Medical Center · US

Funding

NRSA Training CoreTL1TR002318 · NCATS · UNIVERSITY OF WASHINGTON · PI Megan Moore · 2017 to 2026
$8.4M
An integrated strategy to define the functional and synergistic impact of T1D causal variantsDP3DK111802 · NIDDK · SEATTLE CHILDREN'S HOSPITAL · PI RAWLINGS, DAVID J · 2016 to 2016
$4.4M
NCATS NIH HHS TL1 TR002318NIDDK NIH HHS DP3 DK111802
6 · The paper itself

Abstract

Risk of autoimmunity is associated with multiple genetic variants. Genome-wide association studies have linked single-nucleotide polymorphisms in the phosphatases

Indexed as

AllelesAutoimmunityBlood DonorsCD4-Positive T-LymphocytesCells, CulturedCRISPR-Cas SystemsGene EditingGenome-Wide Association StudyHumansInterleukin-2PhenotypePolymorphism, Single NucleotideProtein Tyrosine Phosphatase, Non-Receptor Type 2Protein Tyrosine Phosphatase, Non-Receptor Type 22Receptors, Antigen, T-CellSignal TransductionIL2 protein, humanInterleukin-2Protein Tyrosine Phosphatase, Non-Receptor Type 2Protein Tyrosine Phosphatase, Non-Receptor Type 22PTPN22 protein, humanPTPN2 protein, humanReceptors, Antigen, T-CellSOCS3 protein, humanSuppressor of Cytokine Signaling 3 ProteinZAP70 protein, humanZAP-70 Protein-Tyrosine Kinase

Identifiers

PMID31722988
PMCPMC6904544
OpenAlexW2993401748

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.